| # | Drug | Count |
|---|---|---|
| 0 | METRONIDAZOLE | 12 |
| 1 | METRONIDAZOLE TOPICAL | 12 |
| 2 | CYTARABINE | 11 |
| 3 | ALENDRONATE SODIUM | 10 |
| 4 | AMPHOTERICIN B | 10 |
| 5 | CEFUROXIME | 10 |
| 6 | IRON | 10 |
| 7 | MEROPENEM | 10 |
| 8 | OXYTOCIN | 10 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 1 | DINOPROSTONE | 4 | 0.0049 |
| 2 | DAUNORUBICIN HYDROCHLORIDE | 7 | 0.0042 |
| 3 | OXYTOCIN | 10 | 0.0033 |
| 4 | BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE | 1 | 0.0025 |
| 5 | MAGNESIUM SALICYLATE | 1 | 0.0017 |
| 6 | FOSFOMYCIN TROMETHAMINE | 1 | 0.0016 |
| 7 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| 8 | CEFUROXIME | 10 | 0.0009 |
| 9 | MEPIVACAINE HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 16 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 13 |
| 2 | Nitroimidazole Antimicrobial [EPC] | 12 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 10 |
| 4 | Oxytocic [EPC] | 10 |
| 5 | Penem Antibacterial [EPC] | 10 |
| 6 | Polyene Antifungal [EPC] | 10 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 8 | Alkylating Drug [EPC] | 6 |
| 9 | Kinase Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 10 | 0.0033 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 10 | 0.0008 |
| 2 | Penem Antibacterial [EPC] | 10 | 0.0003 |
| 3 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Polyene Antifungal [EPC] | 10 | 0.0002 |
| 5 | Stimulant Laxative [EPC] | 3 | 0.0002 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 12 | 0.0002 |
| 9 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |